Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI

Effect of Covid-19 Epidemic on Primary PCI and Prognosis in Patients With Acute STEMI

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04427735

Enrollment

200

Registered

2020-06-11

Start date

2019-01-24

Completion date

2021-07-24

Last updated

2020-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI

Keywords

covid-19, STEMI, primary PCI

Brief summary

The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic,which provide effective suggestions and strategies for emergency and severe treatment.

Detailed description

The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. The patients' prognosis is poor because the epidemic situation runs on medical resources, delays the diagnosis and treatment of other diseases such as cardiovascular diseases, and the patients' willingness to see a doctor is reduced. In particular, the delay in the treatment of STEMI, which needs PCI treatment, will cause more damage to the patients. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic. In this study, STEMI patients who experienced emergency PCI treatment after the covid-19 outbreak in 2020 were included, and compared with the data of the same period in 2019,we will analyze the pre hospital treatment time, vascular opening time,and the major cardiovascular adverse events, which provide effective suggestions and strategies for emergency and severe treatment.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Continuous inclusion of patients with definite diagnosis of acute ST segment elevation myocardial infarction and emergency PCI intervention.

Exclusion criteria

* Febrile patients, patients with severe infection, * ST segment elevation myocardial infarction during hospitalization, * Patients who could not cooperate with each other.

Design outcomes

Primary

Measure	Time frame	Description
MACE (major adverse cardiovascular events)	1 year	cardiovascular death, re-infarction, malignant arrhythmia,heart failure, revascularization, and stroke
all-cause death	1 year	death caused by all reason

Countries

China

Contacts

Primary ContactHongwei Li, doctor

lhw19656@sina.com0086 10 63139780

Outcome results